Effects of Acetylsalicylic Acid on Increase of Fibrin Network Porosity and the Consequent Upregulation of Fibrinolysis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2009-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/FJC.0b013e3181953e0fPMID 19129740
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aspirin: promise and resistance in the new millennium.

  2008cited by this paper
• Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials

  2005cited by this paper
• Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism

  2003cited by this paper
• Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events.

  2002cited by this paper
• The way I see it: House officers need formal career development

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Analyzing fibrin clot structure using a microplate reader

  2002cited by this paper
• Modified Clotting Properties of Fibrinogen in the Presence of Acetylsalicylic Acid in a Purified System

  2001cited by this paper
• Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

  2000cited by this paper
• The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.

  2000cited by this paper
• Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid.

  1998cited by this paper
• Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?

  1996cited by this paper
• Variability in the Pharmacokinetics and Pharmacodynamics of Low Dose Aspirin in Healthy Male Volunteers

  1995cited by this paper
• Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.

  1995influential reference
• The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator

  1995cited by this paper
• Absorption Kinetics of Low Dose Aspirin in Patients with Evolving Acute Myocardial Infarction

  1994cited by this paper
• Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation.

  1994influential reference
• Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure.

  1993cited by this paper
• The effect of fibrin structure on fibrinolysis.

  1992cited by this paper
• Native fibrin gel networks and factors influencing their formation in health and disease.

  1990cited by this paper
• Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels.

  1989cited by this paper
• Native fibrin gel networks observed by 3D microscopy, permeation and turbidity.

  1989cited by this paper
• ASPIRIN ACETYLATES FIBRINOGEN AND ENHANCES FIBRINOLYSIS IN VIVO. FIBRINOLYTIC EFFECT IS INDEPENDENT OF CHANGES IN PLASMINOGEN ACTIVATOR LEVELS

  1987cited by this paper
• Aspirin: plasma concentration and effects.

  1983cited by this paper
• Sodium salicylate interferes with the inhibitory effects of aspirin and indomethacin on human platelets.

  1983cited by this paper
• Salicylate inhibition of antiplatelet effect of aspirin.

  1981cited by this paper
• Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.

  1981cited by this paper
• Dose-dependent influence of acetylsalicyclic acid on platelet functions and plasmatic coagulation factors.

  1976cited by this paper
• The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.

  1975cited by this paper
• In vitro Acetylation of Plasma Proteins, Enzymes and DNA by Aspirin

  1968cited by this paper

• Prevention of unfavorable fibrin clots and thrombo-embolic manifestations in patients with cardiovascular disease

  2025cites this paper
• Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation

  2024cites this paper
• Thrombosis and Aging: Fibrin Clot Properties and Oxidative Stress

  2023cites this paper
• Fibrinolysis Regulation: A Promising Approach to Promote Osteogenesis

  2022cites this paper
• Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes

  2021cites this paper
• Fibrin Clot Formation under Oxidative Stress Conditions

  2021cites this paper
• Patients scheduled for TAVI tend to form abnormal fibrin clots more resistant to lysis: the impact of age.

  2021cites this paper
• Development of a mesoscopic framework spanning nanoscale protofibril dynamics to macro-scale fibrin clot formation

  2021cites this paper
• Quantitative analysis of clot density, fibrin fiber radius, and protofibril packing in acute phase myocardial infarction.

  2021cites this paper
• Fibrin Network Porosity and Endo-/Exogenous Thrombin Cross-talk

  2021cites this paper
• The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro—Inference from Data Review

  2020cites this paper
• Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis

  2019cites this paper
• Neutrophil extracellular traps in thrombi retrieved during interventional treatment of ischemic arterial diseases.

  2019cites this paper
• Comparison of Visual Pathology Secondary to the Light of Polymerization. Bibliographic Review of the 5 Main Types of Light in the Market

  2018cites this paper
• Role of thromboxane-dependent platelet activation in venous thrombosis: Aspirin effects in mouse model.

  2016cites this paper
• Clot Formation in the Presence of Acetylsalicylic Acid Leads to Increased Lysis Rates Regardless of the Chosen Thrombolysis Strategy

  2016cites this paper
• Gender Differences in Fibrin Polymerization and Lysability of Fibrin in Patients with Atrial Fibrillation.

  2016cites this paper
• Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events

  2016cites this paper
• Clot properties and cardiovascular disease

  2014cites this paper
• Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid

  2014cites this paper
• The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease

  2014cites this paper
• Oxidative Modification of Fibrinogen Is Associated With Altered Function and Structure in the Subacute Phase of Myocardial Infarction

  2014cites this paper
• Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure

  2013cites this paper
• Mechanisms of fibrin polymerization and clinical implications.

  2013cites this paper
• In vitro studies using a global hemostasis assay to examine the anticoagulation effects in plasma by the direct thrombin inhibitors: dabigatran and argatroban

  2013cites this paper
• A history of early stent thrombosis is associated with prolonged clot lysis time

  2012cites this paper
• Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: a mass spectrometric and isotope labeling study.

  2012cites this paper
• Alternative Mechanism of Aspirin in Anti-Thrombotic Therapy: Inhibition of Thrombin Activatable Fibrinolysis Inhibitor

  2012cites this paper
• Molecular Mechanisms Affecting Fibrin Structure and Stability

  2011cites this paper
• Role of fibrin structure in thrombosis and vascular disease.

  2011cites this paper
• STUDIES OF PLATELET FUNCTION, AND EFFECTS OF ASPIRIN AND CLOPIDOGREL TREATMENT

  2011cites this paper
• Studies of haemostasis in acute coronary syndromes and diabetes mellitus

  2011cites this paper
• Studies of platelet function, and effects of aspirin and clopidogrel treatment

  2011cites this paper
• Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke.

  2011cites this paper
• Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases.

  2011cites this paper
• Lord Molecular Origin of Fibrin Structure and Stability 495

  2011cites this paper
• Nanoparticle diffusion measures bulk clot permeability.

  2011cites this paper
• Small particle transport in fibrin gels and high throughput clot characterization

  2010cites this paper
• Molecular aspects in clinical hemostasis research at Karolinska Institutet.

  2010cites this paper
• Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease.

  2010cites this paper